Fifth Third Bancorp’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Fifth Third Bancorp’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-40	Closed	-$1K	–	2383
2020 Q2	$1K	Hold	40	–	–	﹤0.01%	2050
2020 Q1	$1K	Hold	40	–	–	﹤0.01%	2084
2019 Q4	$1K	Buy	+40	New	+$957	﹤0.01%	2176

Other funds holding VYNT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fifth Third Bancorp's VYNT Position: Q3 2020 in Review

Fifth Third Bancorp sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2020, closing a stake of 40 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in VYNT in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 10 funds tracked by Wall St. Rank hold VYNT as of Q3 2020.

Fifth Third Bancorp reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Fifth Third Bancorp sold 40 Vyant Bio, Inc. Common Stock shares in Q3 2020, an estimated $1K.
Fifth Third Bancorp first reported a position in Vyant Bio, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
Fifth Third Bancorp's Vyant Bio, Inc. Common Stock position peaked at $1K in Q2 2020.
10 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2020.

Based on Fifth Third Bancorp's 13F filing for Q3 2020, filed 9 Nov 2020.